JP Morgan maintains Revvity at Neutral, raises price target to $160 from $155

What happened

JP Morgan kept its rating on Revvity at Neutral and raised its price target, an estimate of a possible future share price, to $160 from $155. The new target is 3.2% higher than before and implies 2.1% downside from Revvity’s November 3 closing price of $163.48.

Confirmed

Global impact / market context

The higher target signals a modestly improved view from JP Morgan, but its Neutral rating is unchanged and the target remains below the cited closing price. The rating and target may shape investor expectations, though they do not determine Revvity’s sales, costs, or cash available.

Analyst inference

The article says five recent analyst notes over the past 30 days set targets between $172 and $185, all above JP Morgan’s new $160 target. This shows JP Morgan’s estimate is comparatively cautious, but the article reports no resulting share-price reaction.

Confirmed

What to watch

1. Whether JP Morgan changes its Neutral rating or $160 target in a later note would indicate whether its view shifts beyond this small target increase. Analyst inference
2. Future company results could show whether Revvity’s revenue and costs support a higher share valuation; this article provides no operating results or forecasts. Analyst inference
3. The cited recent analyst targets range from $172 to $185, while JP Morgan’s new target is $160; further published notes could change that comparison. Confirmed

Evidence

• Original source link unavailable